NCT04749680

Comparison of Efficacy and Tolerability of APD Treatment With Different PD Cyclers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Fresenius Medical Care Deutschland GmbH · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study has been designed in order to investigate the performance and safety of the new Silencia PD cycler including the Silencia tubing system in comparison to the PD-Night and Homechoice PD cycler which are both well-established PD cyclers.

Conditions

• Renal Failure
• End Stage Renal Disease

Interventions

Type	Name	Description
DEVICE	PD cycler Silencia	Treatment for 2 weeks either with PD-Night or Homechoice PD cycler (Comparators) depending on the previous Treatment ((clinical phase I). At the end of these 2 treatment weeks and a subsequent training phase which up to 3 weeks, treatment with the Silencia PD cycler for 2 further weeks (clinical phase II).

Timeline

• Start date: 2021-05-31
• Primary completion: 2021-10-12
• Completion: 2021-10-12
• First posted: 2021-02-11
• Last updated: 2022-08-02

Locations

4 sites across 1 country: Chile